You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 6, June 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acyclovir

Pharmacology and Clinical Experience

Oscar L. Laskin, MD

Arch Intern Med. 1984;144(6):1241-1246.


Abstract

• Acyclovir is a selective antiherpes agent. Its selective activity Is by exploitation of differences between the herpes-specific and host cell enzymes. The major route of elimination of acyclovir Is via the kidney by glomerular filtration and renal tubular secretion. In immunocompromised patients, acyclovir is effective for the prophylaxis and therapy of herpes simplex virus infections and for the treatment of herpes zoster and varicella. In nonimmunocompromised patients, acyclovir is beneficial in the therapy of herpes keratoconjunctivitis and in the therapy of genital herpes, with maximal benefit seen in those patients who have primary genital herpes. There is some benefit from acyclovir administration in patients with herpes zoster who are otherwise normal. The toxic reactions to acyclovir consist of phlebitis, local irritation, and occasionally, reversible renal dysfunction. Dose reduction is recommended in patients with impaired renal function.

(Arch Intern Med 1984;144:1241-1246)



Author Affiliations

From the Division of Clinical Pharmacology, Department of Medicine and Pharmacology, Cornell University Medical College, New York.


Footnotes

Accepted for publication Nov 7, 1983.

Reprint requests to Division of Clinical Pharmacology, Cornell University Medical College, 1300 York Ave, New York, NY 10021 (Dr Laskin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Delayed acute retinal necrosis after herpetic encephalitis
PAVESIO et al.
Br J Ophthalmol 1997;81:415a-415.
FULL TEXT  

Treatment of Adult Chickenpox With Oral Acyclovir
Feder
Arch Intern Med 1990;150:2061-2065.
ABSTRACT  

No, Brain Biopsy Need Not Be Done in Every Patient Suspected of Having Herpes Simplex Encephalitis
Fishman
Arch Neurol 1987;44:1291-1292.
ABSTRACT  

Concomitant Herpes Simplex Virus Type 1 and Cytomegalovirus Ventriculoencephalitis in Acquired Immunodeficiency Syndrome
Laskin et al.
Arch Neurol 1987;44:843-847.
ABSTRACT  

Long-term Suppression of Recurrent Herpes Labialis by Low-Dose Oral Acyclovir in an Immunocompromised Patient
Dan et al.
Arch Intern Med 1986;146:1438-1440.
ABSTRACT  

Acyclovir and Suppression of Frequently Recurring Herpetic Whitlow
LASKIN
ANN INTERN MED 1985;102:494-495.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.